These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66. Pazopanib, a multikinase angiogenesis inhibitor, in patients with relapsed or refractory advanced soft tissue sarcoma: a phase II study from the European organisation for research and treatment of cancer-soft tissue and bone sarcoma group (EORTC study 62043). Sleijfer S; Ray-Coquard I; Papai Z; Le Cesne A; Scurr M; Schöffski P; Collin F; Pandite L; Marreaud S; De Brauwer A; van Glabbeke M; Verweij J; Blay JY J Clin Oncol; 2009 Jul; 27(19):3126-32. PubMed ID: 19451427 [TBL] [Abstract][Full Text] [Related]
67. Histopathological re-classification of extremity pleomorphic soft tissue sarcoma has clinical relevance. Massi D; Beltrami G; Capanna R; Franchi A Eur J Surg Oncol; 2004 Dec; 30(10):1131-6. PubMed ID: 15522563 [TBL] [Abstract][Full Text] [Related]
68. Assessing the Role of Neoadjuvant Chemotherapy in Primary High-Risk Truncal/Extremity Soft Tissue Sarcomas: An Analysis of the Multi-institutional U.S. Sarcoma Collaborative. Zaidi MY; Ethun CG; Tran TB; Poultsides G; Grignol VP; Howard JH; Bedi M; Mogal H; Tseng J; Roggin KK; Chouliaras K; Votanopoulos K; Krasnick B; Fields RC; Oskouei S; Reimer N; Monson D; Maithel SK; Cardona K Ann Surg Oncol; 2019 Oct; 26(11):3542-3549. PubMed ID: 31342400 [TBL] [Abstract][Full Text] [Related]
70. Caffeine-potentiated chemotherapy and conservative surgery for high-grade soft-tissue sarcoma. Tsuchiya H; Tomita K; Yamamoto N; Mori Y; Asada N Anticancer Res; 1998; 18(5B):3651-6. PubMed ID: 9854472 [TBL] [Abstract][Full Text] [Related]
71. [Clinical efficacy and safety of apatinib combined with chemotherapy for osteosarcoma and soft tissue sarcoma with pulmonary metastasis]. Li SL; Yang QK; Chen P; Zheng K; Wang W; Pei Y; Zhang XJ Zhonghua Zhong Liu Za Zhi; 2019 Apr; 41(4):309-314. PubMed ID: 31014058 [No Abstract] [Full Text] [Related]
72. Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma. De Sanctis R; Marrari A; Marchetti S; Mussi C; Balzarini L; Lutman FR; Daolio P; Bastoni S; Bertuzzi AF; Quagliuolo V; Santoro A Drug Des Devel Ther; 2015; 9():5785-91. PubMed ID: 26604682 [TBL] [Abstract][Full Text] [Related]
73. Endostar combined with chemotherapy for treatment of metastatic colorectal and gastric cancer: a pilot study. Zhou JF; Bai CM; Wang YZ; Li XY; Cheng YJ; Chen SC Chin Med J (Engl); 2011 Dec; 124(24):4299-303. PubMed ID: 22340403 [TBL] [Abstract][Full Text] [Related]
74. Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group. Santoro A; Tursz T; Mouridsen H; Verweij J; Steward W; Somers R; Buesa J; Casali P; Spooner D; Rankin E J Clin Oncol; 1995 Jul; 13(7):1537-45. PubMed ID: 7602342 [TBL] [Abstract][Full Text] [Related]
75. Tislelizumab immunotherapy combined with chemotherapy in the treatment of a patient with primary anterior mediastinal undifferentiated pleomorphic sarcoma with high PD-L1 expression: A case report and literature review. Yang H; Qin Z; He X; Xue Q; Zhou H; Sun J; Li X; Zhao T Front Oncol; 2023; 13():1110997. PubMed ID: 37091183 [TBL] [Abstract][Full Text] [Related]
76. [Efficacy of salvage chemotherapy in the advanced non-small cell lung cancer patients who failed the treatment of chemotherapy and EGFR-TKI]. Fan Y; Huang ZY; Yu HF; Luo LH Zhonghua Zhong Liu Za Zhi; 2010 Nov; 32(11):859-63. PubMed ID: 21223694 [TBL] [Abstract][Full Text] [Related]
77. The role of Ifosfamide-doxorubicin chemotherapy in histology-specific, high grade, locally advanced soft tissue sarcoma, a 14-year experience. Goy BW; Syed S; Padmanabhan A; Burchette RJ; Helmstedter CS Radiother Oncol; 2021 Dec; 165():174-178. PubMed ID: 34758339 [TBL] [Abstract][Full Text] [Related]
78. Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial. Le Cesne A; Blay JY; Domont J; Tresch-Bruneel E; Chevreau C; Bertucci F; Delcambre C; Saada-Bouzid E; Piperno-Neumann S; Bay JO; Mir O; Ray-Coquard I; Ryckewaert T; Valentin T; Isambert N; Italiano A; Clisant S; Penel N Lancet Oncol; 2015 Mar; 16(3):312-9. PubMed ID: 25680558 [TBL] [Abstract][Full Text] [Related]
79. Clinical Application of Recombinant Human Endostatin in Postoperative Early Complementary Therapy on Patients with Non-small Cell Lung Cancer in Chinese Mainland. Zhu Q; Zang Q; Jiang ZM; Wang W; Cao M; Su GZ; Zhen TC; Zhang XT; Sun NB; Zhao C Asian Pac J Cancer Prev; 2015; 16(9):4013-8. PubMed ID: 25987078 [TBL] [Abstract][Full Text] [Related]
80. The effect of delayed postoperative irradiation on local control of soft tissue sarcomas of the extremity and torso. Schwartz DL; Einck J; Hunt K; Bruckner J; Conrad E; Koh WJ; Laramore GE Int J Radiat Oncol Biol Phys; 2002 Apr; 52(5):1352-9. PubMed ID: 11955749 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]